SBP1: Peptide binder to the SARS-CoV-2 spike protein

Featured Product New!: Monoclonal Antibodies to Coronavirus SARS-CoV-2 RBD Domain

The SARS-CoV-2 coronavirus invades host cells by binding the angiotensin converting enzyme 2 (ACE2) receptor on human cell surface through its viral spike protein (S). A helical peptide sequence (spike-binding peptide 1, SBP1) derived from the α1 helix of ACE2 peptidase domain (ACE2-PD) could bind to the SARS-CoV-2 coronavirus. The SBP1 peptide specifically binds SARS-CoV-2-RBD with low nanomolar affinity.

A 23-mer peptide sequence (SBP1) was synthesized by LifeTein microwave peptide synthesis. The 23 residues selected from the ACE2 α1 helix sequence (SBP1: IEEQAKTFLDKFNHEAEDLFYQS) could be used as the SARS-CoV-2 spike protein binder.

See full description about this spike protein binder here.

Catalog number: LT-V007, 23aa

Peptide sequence: SBP1: IEEQAKTFLDKFNHEAEDLFYQS

Three letter sequence:NH2- Ile - Glu - Glu - Gln - Ala - Lys - Thr - Phe - Leu - Asp - Lys - Phe - Asn - His - Glu - Ala - Glu - Asp - Leu - Phe - Tyr - Gln - Ser -CONH2

Quantity: 4mg

Purity: >95% by HPLC

Molecular Weight: 2802.01 g/mol

  • 0 Units in Stock

Ask a Question

$540.00 $320.00Save: 41% off

Add to Cart:
LifeTein LifeTein provides custom peptide synthesis service, recombinant proteins, peptides, cytokines, custom antibody service and custom protein service. LifeTein is the world leader in fast peptide synthesis service with lab facility located in New Jersey USA. LifeTein Logo 100 Randolph Road, Suite 2D, Somerset USA New Jersey 08873
Copyright © 2024 LifeTein.com. Powered by LifeTein